Alcon Research, Ltd. v. Watson Laboratories, Inc. et al
Alcon Research, Ltd. |
Watson Laboratories, Inc., Actavis, Inc. and Actavis Pharma, Inc. |
1:2016cv00129 |
March 4, 2016 |
US District Court for the District of Delaware |
Wilmington Office |
New Castle |
Sue L. Robinson |
Patent |
35 U.S.C. ยง 271 |
None |
Available Case Documents
The following documents for this case are available for you to view or download:
Document Text |
---|
Filing 177 MEMORANDUM ORDER re 152 Objections filed by Alcon Research, Ltd. are SUSTAINED. The constructions set forth in 150 REPORT AND RECOMMENDATION are NOT adopted. Signed by Judge Leonard P. Stark on 4/17/18. (ntl) |
Filing 147 MEMORANDUM ORDER re 58 REPORT AND RECOMMENDATION regarding claim construction is ADOPTED. Signed by Judge Leonard P. Stark on 11/9/17. (ntl) |
Filing 58 REPORT AND RECOMMENDATIONS. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 3/6/2017. Signed by Judge Sherry R. Fallon on 2/15/17. (cak) |
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.